Contribute Try STAT+ Today

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal for weekend daydreams. Our agenda looks to be rather modest. We hope to catch up on some reading, manicure the Pharmalot campus grounds and play a canine version of rugby with our official mascot, who is quite a competitor. If time permits, we may also have a listening party. And what about you? This is a fine time to stroll among apple orchards or take a drive in the country. You could winterize your castle. Or boost the economy by purchasing a few sweaters. Well, whatever you do, have a grand time. But be safe Enjoy, and see you soon…

In a highly unusual move, the Centers for Disease Control and Prevention director Rochelle Walensky overruled a recommendation by an agency advisory panel that had refused to endorse booster shots of the Pfizer (PFE) -BioNTech (BNTX) Covid-19 vaccine for frontline workers, The New York Times tells us. The CDC panel recommended boosters for a wide range of Americans, including tens of millions of older adults and younger people at high risk for the disease, but excluded health care workers, teachers and others whose jobs put them at risk.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment